X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3401) 3401
Newspaper Article (217) 217
Newsletter (191) 191
Book Chapter (61) 61
Magazine Article (48) 48
Transcript (6) 6
Trade Publication Article (4) 4
Reference (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aspirin (2860) 2860
humans (2555) 2555
science & technology (2514) 2514
life sciences & biomedicine (2445) 2445
male (1286) 1286
platelet aggregation inhibitors - therapeutic use (1274) 1274
aspirin - therapeutic use (1247) 1247
female (1225) 1225
ticlopidine - analogs & derivatives (1217) 1217
cardiovascular system & cardiology (1195) 1195
stroke (1051) 1051
aged (1028) 1028
clopidogrel (1020) 1020
middle aged (1002) 1002
drug therapy, combination (963) 963
cardiac & cardiovascular systems (870) 870
ticlopidine - therapeutic use (804) 804
risk factors (771) 771
abridged index medicus (730) 730
treatment outcome (724) 724
heart attacks (720) 720
drug therapy (694) 694
aspirin - administration & dosage (691) 691
platelet aggregation inhibitors - administration & dosage (660) 660
platelet aggregation inhibitors - adverse effects (620) 620
anticoagulants (569) 569
aspirin - adverse effects (569) 569
cardiovascular disease (560) 560
cardiology (543) 543
care and treatment (540) 540
acute coronary syndromes (500) 500
thrombosis (476) 476
peripheral vascular disease (457) 457
prevention (452) 452
patients (448) 448
ticlopidine - administration & dosage (444) 444
stents (437) 437
mortality (434) 434
coronary heart disease (417) 417
stroke - prevention & control (414) 414
general & internal medicine (408) 408
blood platelets (402) 402
clinical trials (393) 393
research (391) 391
medicine, general & internal (389) 389
pharmacology & pharmacy (388) 388
medicine & public health (364) 364
cardiac patients (350) 350
analysis (347) 347
ticlopidine - adverse effects (346) 346
dosage and administration (344) 344
cardiovascular diseases (333) 333
hemorrhage - chemically induced (332) 332
adult (324) 324
bleeding (320) 320
hematology (313) 313
cardiovascular (312) 312
aged, 80 and over (311) 311
ischemia (304) 304
anticoagulants - therapeutic use (301) 301
time factors (301) 301
coronary vessels (296) 296
studies (288) 288
medical research (277) 277
atrial fibrillation (271) 271
risk assessment (263) 263
health aspects (262) 262
randomized controlled trials as topic (261) 261
myocardial infarction (260) 260
neurosciences & neurology (260) 260
internal medicine (259) 259
platelet aggregation inhibitors - pharmacology (253) 253
drug dosages (248) 248
medicine, experimental (236) 236
prospective studies (235) 235
aspirin - pharmacology (233) 233
fibrinolytic agents - therapeutic use (232) 232
warfarin (228) 228
platelet aggregation - drug effects (226) 226
hemorrhage (224) 224
clinical neurology (216) 216
diabetes (215) 215
percutaneous coronary intervention (215) 215
secondary prevention (214) 214
retrospective studies (213) 213
antiplatelet therapy (211) 211
acute coronary syndrome - drug therapy (210) 210
surgery (208) 208
follow-up studies (207) 207
cardiac arrhythmia (205) 205
stroke - drug therapy (193) 193
angioplasty (189) 189
blood platelets - drug effects (187) 187
aggregation (186) 186
platelets (184) 184
double-blind method (183) 183
heart attack (183) 183
usage (182) 182
complications and side effects (181) 181
anticoagulants - adverse effects (180) 180
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3885) 3885
German (20) 20
French (18) 18
Chinese (11) 11
Japanese (9) 9
Korean (7) 7
Spanish (6) 6
Portuguese (2) 2
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC. Cardiovascular interventions, ISSN 1936-8798, 07/2017, Volume 10, Issue 13, pp. 1357 - 1365
Objectives The aim of this study was to compare aspirin plus clopidogrel with aspirin alone as antithrombotic treatment following transcatheter aortic valve replacement (TAVR... 
clopidogrel | aspirin | aortic stenosis | bleeding | transcatheter aortic valve replacement | stroke | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | South America | Humans | Male | Aortic Valve - surgery | Prosthesis Design | Aspirin - administration & dosage | Early Termination of Clinical Trials | Fibrinolytic Agents - adverse effects | Ischemic Attack, Transient - prevention & control | Time Factors | Aspirin - adverse effects | Ischemic Attack, Transient - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Infarction - etiology | Balloon Valvuloplasty - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Transcatheter Aortic Valve Replacement - adverse effects | Transcatheter Aortic Valve Replacement - instrumentation | Stroke - prevention & control | Europe | Heart Valve Prosthesis | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Ticlopidine - analogs & derivatives | Canada | Stroke - etiology | Thrombosis - etiology | Clopidogrel | Aged | Fibrinolytic Agents - administration & dosage | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Thrombosis - mortality | Transcatheter Aortic Valve Replacement - mortality | Thrombosis - diagnosis | Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 09/2014, Volume 130, Issue 11 Suppl 1, pp. S12 - S18
.... METHODS AND RESULTS—In the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) trial, a total of 113 patients were randomized to receive aspirin plus clopidogrel or aspirin plus placebo for 1 year after coronary artery bypass grafting... 
Clopidogrel | Coronary artery disease | Platelet aggregation | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Artery Disease - surgery | Follow-Up Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Postoperative Complications - prevention & control | Male | Aspirin - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Female | Aspirin - therapeutic use | Diabetes Complications - surgery | Platelet Aggregation Inhibitors - therapeutic use | Multicenter Studies as Topic - statistics & numerical data | Double-Blind Method | Risk Factors | Coronary Restenosis - prevention & control | Coronary Stenosis - drug therapy | Diabetes Complications - drug therapy | Postoperative Complications - epidemiology | Coronary Artery Disease - drug therapy | Disease Progression | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Restenosis - epidemiology | Coronary Stenosis - surgery | Coronary Artery Bypass | Aged | Heart | Aspirin | Usage | Care and treatment | Surgery | Diagnosis | Coronary heart disease | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2006, Volume 367, Issue 9526, pp. 1903 - 1912
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 2010, Volume 122, Issue 25, pp. 2680 - 2687
Journal Article
Lancet neurology, ISSN 1474-4422, 10/2008, Volume 7, Issue 10, pp. 875 - 884
...) and 200 mg extended-release dipyridamole (ER-DP) twice a day or 75 mg clopidogrel once a day, and either 80 mg telmisartan or placebo once per day... 
Neurology | SYSTOLIC HYPERTENSION | MINI-MENTAL-STATE | VASCULAR DEMENTIA | RATS | CANDESARTAN | BASE-LINE DATA | COMBINATION | CEREBRAL-ISCHEMIA | UMCG Approved | CEREBROVASCULAR-DISEASE | ELDERLY SCOPE | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Benzoates - therapeutic use | Follow-Up Studies | Ticlopidine - therapeutic use | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Male | Secondary Prevention | Stroke - physiopathology | Drug Delivery Systems | Mental Status Schedule | Female | Aspirin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Disability Evaluation | Severity of Illness Index | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | International Cooperation | Cognition - drug effects | Ticlopidine - analogs & derivatives | Aged | Prevention | Stroke (Disease) | Medical colleges | Care and treatment | Ischemia | Analysis | Dipyridamole | Clinical trials | Index Medicus | Drugs | Neuroprotection | Angiotensin II receptors | Aspirin | Stroke | Motivation | Cognitive ability | Dementia disorders | Clopidogrel | Age | Recurrence | Benzimidazoles | Neurons and Cognition | Cognition | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Benzoates | Ticlopidine | Platelet Aggregation Inhibitors | Santé publique et épidémiologie
Journal Article
Journal Article
Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 5, pp. 489 - 497
Journal Article